Literature DB >> 35671347

Hypertension and Racial Differences in Dementia Reveal a Strategy for Risk Reduction in All Races.

David S Knopman1, Sandra J Taler2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35671347      PMCID： PMC9340640          DOI： 10.1093/ajh/hpac073

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN： 0895-7061            Impact factor:   3.080


× No keyword cloud information.
  20 in total

1.  Change in blood pressure and incident dementia: a 32-year prospective study.

Authors:  Robert Stewart; Qian-Li Xue; Kamal Masaki; Helen Petrovitch; G Webster Ross; Lon R White; Lenore J Launer
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

Review 2.  Systematic review of dementia prevalence and incidence in United States race/ethnic populations.

Authors:  Kala M Mehta; Gwen W Yeo
Journal:  Alzheimers Dement       Date:  2016-09-04       Impact factor: 21.566

3.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.

Authors:  Rebecca F Gottesman; Andrea L C Schneider; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura Coker; Josef Coresh; David Knopman; Melinda C Power; Andreea Rawlings; A Richey Sharrett; Lisa M Wruck; Thomas H Mosley
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

4.  Racial differences in the impact of elevated systolic blood pressure on stroke risk.

Authors:  George Howard; Daniel T Lackland; Dawn O Kleindorfer; Brett M Kissela; Claudia S Moy; Suzanne E Judd; Monika M Safford; Mary Cushman; Stephen P Glasser; Virginia J Howard
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

5.  Neuropathologic differences by race from the National Alzheimer's Coordinating Center.

Authors:  Neill R Graff-Radford; Lilah M Besser; Julia E Crook; Walter A Kukull; Dennis W Dickson
Journal:  Alzheimers Dement       Date:  2016-04-16       Impact factor: 21.566

6.  Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study.

Authors:  David S Knopman; Rebecca F Gottesman; A Richey Sharrett; Amanda L Tapia; Sonia DavisThomas; B Gwen Windham; Laura Coker; Andrea L C Schneider; Alvaro Alonso; Josef Coresh; Marilyn S Albert; Thomas H Mosley
Journal:  Alzheimers Dement       Date:  2018-05-12       Impact factor: 21.566

7.  Treatment Intensification and Missed Visits as Important Targets for Reducing Racial and Ethnic Disparities in Hypertension Control.

Authors:  Yvonne Commodore-Mensah; Cheryl Dennison Himmelfarb
Journal:  JAMA Cardiol       Date:  2022-02-01       Impact factor: 14.676

8.  Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control.

Authors:  Valy Fontil; Lucia Pacca; Brandon K Bellows; Elaine Khoong; Charles E McCulloch; Mark Pletcher; Kirsten Bibbins-Domingo
Journal:  JAMA Cardiol       Date:  2022-02-01       Impact factor: 30.154

9.  Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.

Authors:  Prashanthi Vemuri; Timothy G Lesnick; Scott A Przybelski; David S Knopman; Greg M Preboske; Kejal Kantarci; Mekala R Raman; Mary M Machulda; Michelle M Mielke; Val J Lowe; Matthew L Senjem; Jeffrey L Gunter; Walter A Rocca; Rosebud O Roberts; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2015-01-15       Impact factor: 13.501

Review 10.  Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence.

Authors:  Carey E Gleason; Megan Zuelsdorff; Diane C Gooding; Amy J H Kind; Adrienne L Johnson; Taryn T James; Nickolas H Lambrou; Mary F Wyman; Fred B Ketchum; Alexander Gee; Sterling C Johnson; Barbara B Bendlin; Henrik Zetterberg
Journal:  Alzheimers Dement       Date:  2021-12-06       Impact factor: 16.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.